Among them, MM patients with the high infiltrating proportion of CD8+ T cells have a higher survival probability (p-value < .01), which is consistent with CD8+ T cells participating in cellular immunity to eliminate tumor cells and slow down the development of the disease. This evidence concerns the gene CD8A and Miyoshi myopathy.